CAPRICOR THERAPEUTICS, INC. — Director's Dealing 2008

Jan 30, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nile Therapeutics, Inc. (NILT.OB)
CIK: 0001133869
Period of Report: 2008-01-25

Reporting Person: SCHAFER GREGORY W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-01-25	Non-Qualified Stock Option (right to buy)	$4.5	A	60000	Acquired	2018-01-25	Common Stock (60000)	Direct

Footnotes

F1: The shares subject to the option vest in three equal installments on January 25, 2009, January 25, 2010 and January 25, 2011.